4DMT
is a California-based biotechnology company that researches and develops gene therapeutics for the treatment of eye, liver and heart diseases... Read more4DMT
is a California-based biotechnology company that researches and develops gene therapeutics for the treatment of eye, liver and heart diseases... Read more
News
Mar 03, 2025
Owler
4D Molecular Therapeutics, Inc.: 4DMT's employee count changed from 147 in Dec 2023 to 227 in Dec 2024
Mar 01, 2025
Life Care News
4DMT: 4DMT Reports Full Year 2024 Financial Results, Operational Highlightsand Expected Upcoming Milestones
Feb 28, 2025
Marketscreener
4DMT: 4D Molecular Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024
Feb 19, 2025
Benzinga
4DMT: 4DMT to Participate in Upcoming Investor Conferences
Feb 18, 2025
Seeking Alpha
4DMT: 4D Molecular Therapeutics: A Smart Bet On Long-Term VEGF Suppression
Feb 11, 2025
PR Newswire
Press Release: 4DMT : INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 4D Molecular Therapeutics, Inc. - FDMT
Feb 10, 2025
Benzinga
4DMT: Eye Disease Focused 4D Molecular Therapeutics Lays Out 52-Week Results From Wet AMD Study
Feb 09, 2025
Nasdaq
4DMT: 4D Molecular Therapeutics Reports Positive Interim Data From Phase 2b Trial For Wet AMD
Jan 29, 2025
centralcharts
Press Release: 4DMT : 4DMT Announces Corporate Webcast to Review Interim 52-week Results from the Phase 2b Cohort of PRISM in a Broad Wet AMD Population
Jan 16, 2025
Eyewire News
4DMT: 4DMT Announces Positive Interim Data from 4D-150 SPECTRA Clinical Trial in DME
4DMT Competitors
1
2
3
4
5
6
7
8
9
10